hydroxychloroquine has been researched along with Vasculitis in 27 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methotrexate is successfully used in the treatment of arthritis but little is known about its effects on extra-articular manifestations of rheumatoid arthritis." | 7.68 | Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. ( Anaya, JM; Combe, B; Didry, C; Gutierrez, M; Sany, J, 1993) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 6.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| " Treatment of the patient with prednisone, colchicine and hydroxychloroquine led to the improvement of the cutaneous vasculitis and a drop in ESR, serum gamma globulins and IgM and IgG rheumatoid factors." | 4.79 | Hypergammaglobulinemic purpura of Waldenstrom associated with systemic lupus erythematosus: report of a case and review of the literature. ( Habib, GS; Quismorio, FP; Stimmer, MM, 1995) |
| " The patient received induction therapy with steroids, cyclophosphamide and hydroxychloroquine followed by rapid clinical improvement and remission of proteinuria." | 3.96 | A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis. ( Boletis, JN; Liapis, G; Marinaki, S; Skalioti, C; Vallianou, K, 2020) |
| "Methotrexate is successfully used in the treatment of arthritis but little is known about its effects on extra-articular manifestations of rheumatoid arthritis." | 3.68 | Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. ( Anaya, JM; Combe, B; Didry, C; Gutierrez, M; Sany, J, 1993) |
| "The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all over the world." | 2.66 | The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. ( Li, T; Liu, Z; Qin, Y; Wang, J; Wang, Q; Yan, X; Zeng, X; Zhang, F; Zhang, S; Zhang, W; Zhang, X; Zhao, Y, 2020) |
| " Studies included were trials in which: (1) the participants were classified as having GCA by the 1990 ACR criteria or biopsy proven disease; (2) parallel-group randomised control of at least 16 weeks duration had been conducted with at least 20 participants; (3) the design included either alternative adjunct immunosuppressant regimens, alternative GCs dosing or routes of administration; and (4) outcome data was included on either relapse rates or rates of infection." | 2.50 | Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. ( Loke, YK; MacGregor, AJ; Watts, RA; Yates, M, 2014) |
| "Diffuse alveolar hemorrhage is an uncommon and often fatal condition in children that is characterized by distinct histopathological etiologies." | 1.51 | Acute pulmonary embolism in a child with ANCA-negative Idiopathic Pulmonary Capillaritis. ( Asseri, AA; Daines, CL; Zeng, Y, 2019) |
| "Hydroxychloroquine was the most frequently filled DMARD (13." | 1.46 | End-stage renal disease in patients with rheumatoid arthritis. ( Bethel, M; Brown, S; Carbone, L; Chen, CC; Nahman, NS; Paudyal, S; Rice, C; Skelton, M; Yang, FM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.11) | 18.7374 |
| 1990's | 4 (14.81) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 12 (44.44) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Su, L | 1 |
| Qi, Z | 1 |
| Guan, S | 1 |
| Wei, L | 1 |
| Zhao, Y | 2 |
| Zhang, W | 1 |
| Zhang, F | 1 |
| Wang, Q | 1 |
| Li, T | 1 |
| Liu, Z | 1 |
| Wang, J | 1 |
| Qin, Y | 1 |
| Zhang, X | 1 |
| Yan, X | 1 |
| Zeng, X | 1 |
| Zhang, S | 1 |
| Vallianou, K | 1 |
| Skalioti, C | 1 |
| Liapis, G | 1 |
| Boletis, JN | 1 |
| Marinaki, S | 1 |
| Murray, K | 1 |
| Quinn, S | 1 |
| Turk, M | 1 |
| O'Rourke, A | 1 |
| Molloy, E | 1 |
| O'Neill, L | 1 |
| Mongey, AB | 1 |
| Fearon, U | 1 |
| Veale, DJ | 1 |
| Bostan, E | 1 |
| Akdogan, N | 1 |
| Gokoz, O | 1 |
| Dogan, S | 1 |
| Jachiet, M | 2 |
| Flageul, B | 2 |
| Bouaziz, JD | 2 |
| Bagot, M | 2 |
| Terrier, B | 2 |
| Asseri, AA | 1 |
| Zeng, Y | 1 |
| Daines, CL | 1 |
| Shadhu, K | 1 |
| Ramlagun, D | 1 |
| Ping, X | 1 |
| Yates, M | 1 |
| Loke, YK | 1 |
| Watts, RA | 1 |
| MacGregor, AJ | 1 |
| Deroux, A | 1 |
| Le Quellec, A | 1 |
| Maurier, F | 1 |
| Cordoliani, F | 1 |
| Godmer, P | 1 |
| Abasq, C | 1 |
| Astudillo, L | 1 |
| Belenotti, P | 1 |
| Bessis, D | 1 |
| Bigot, A | 1 |
| Doutre, MS | 1 |
| Ebbo, M | 1 |
| Guichard, I | 1 |
| Hachulla, E | 1 |
| Héron, E | 1 |
| Jeudy, G | 1 |
| Jourde-Chiche, N | 1 |
| Jullien, D | 1 |
| Lavigne, C | 1 |
| Machet, L | 1 |
| Macher, MA | 1 |
| Martel, C | 1 |
| Melboucy-Belkhir, S | 1 |
| Morice, C | 1 |
| Petit, A | 1 |
| Simorre, B | 1 |
| Zenone, T | 1 |
| Bouillet, L | 1 |
| Frémeaux-Bacchi, V | 1 |
| Guillevin, L | 1 |
| Mouthon, L | 1 |
| Dupin, N | 1 |
| Aractingi, S | 1 |
| Freitas, A | 1 |
| Senra, V | 1 |
| Marinho, A | 1 |
| Guedes, M | 1 |
| Kibune, N | 1 |
| Shimomura, Y | 1 |
| Hasegawa, A | 1 |
| Saeki, T | 1 |
| Umemori, Y | 1 |
| Abe, R | 1 |
| Paudyal, S | 1 |
| Yang, FM | 1 |
| Rice, C | 1 |
| Chen, CC | 1 |
| Skelton, M | 1 |
| Bethel, M | 1 |
| Brown, S | 1 |
| Nahman, NS | 1 |
| Carbone, L | 1 |
| Okan, G | 1 |
| Karaaslan, M | 1 |
| Büyükbabani, N | 1 |
| Rozin, AP | 1 |
| Egozi, D | 1 |
| Ramon, Y | 1 |
| Toledano, K | 1 |
| Braun-Moscovici, Y | 1 |
| Markovits, D | 1 |
| Schapira, D | 1 |
| Bergman, R | 1 |
| Melamed, Y | 1 |
| Ullman, Y | 1 |
| Balbir-Gurman, A | 1 |
| Hasiloglu, ZI | 1 |
| Albayram, S | 1 |
| Tasmali, K | 1 |
| Erer, B | 1 |
| Selcuk, H | 1 |
| Islak, C | 1 |
| Hong, JY | 1 |
| Lai, CC | 1 |
| Chang, YS | 1 |
| Hsiao, KH | 1 |
| Chou, CT | 1 |
| Chen, WS | 1 |
| Francès, C | 2 |
| Barete, S | 2 |
| Ayoub, N | 1 |
| Piette, JC | 2 |
| RUBENSTEIN, M | 1 |
| WOLFF, SM | 1 |
| Lai, TY | 1 |
| Chan, WM | 1 |
| Li, H | 1 |
| Lai, RY | 1 |
| Lam, DS | 1 |
| Le Pelletier, F | 1 |
| Amoura, Z | 1 |
| Lopez, LR | 1 |
| Davis, KC | 1 |
| Kohler, PF | 1 |
| Schocket, AL | 1 |
| Habib, GS | 1 |
| Stimmer, MM | 1 |
| Quismorio, FP | 1 |
| Neumann, R | 1 |
| Foster, CS | 1 |
| Combe, B | 1 |
| Didry, C | 1 |
| Gutierrez, M | 1 |
| Anaya, JM | 1 |
| Sany, J | 1 |
| Krendel, DA | 1 |
| Costigan, DA | 1 |
| Dugowson, CE | 1 |
| Gilliland, BC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nutritional Habits, Does it Affect Coronavirus Disease 2019 (COVID-19) Infection Outcome? An Egyptian Experience[NCT04447144] | 200 participants (Anticipated) | Observational | 2020-06-01 | Recruiting | |||
| Evaluation of Independent Clinical- Laboratory Predictors of Clinical Outcomes in Hospitalized Positive SARS-CoV2 Patients (Outcomes SARS-CoV2)[NCT05162534] | 1,800 participants (Actual) | Observational | 2020-05-29 | Completed | |||
| Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis[NCT04920851] | 23 participants (Anticipated) | Observational | 2021-06-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for hydroxychloroquine and Vasculitis
| Article | Year |
|---|---|
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dap | 2014 |
Hypergammaglobulinemic purpura of Waldenstrom associated with systemic lupus erythematosus: report of a case and review of the literature.
Topics: Adult; Colchicine; Female; gamma-Globulins; Humans; Hydroxychloroquine; Immunoglobulin G; Immunoglob | 1995 |
Management of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyc | 1986 |
23 other studies available for hydroxychloroquine and Vasculitis
| Article | Year |
|---|---|
Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study.
Topics: Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Carotid Artery Diseases; Case-Contr | 2022 |
A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis.
Topics: Aged; Antirheumatic Agents; Arthritis; Chronic Urticaria; Complement System Proteins; Cyclophosphami | 2020 |
COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Attitude to Health; Biological Products; Chloroq | 2021 |
Rapid response to combination of hydroxychloroquine and prednisolone in a patient with refractory hypocomplementemic urticarial vasculitis.
Topics: Humans; Hydroxychloroquine; Prednisolone; Urticaria; Vasculitis | 2020 |
[Hypocomplementemic urticarial vasculitis].
Topics: Colchicine; Complement C1q; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive A | 2018 |
Acute pulmonary embolism in a child with ANCA-negative Idiopathic Pulmonary Capillaritis.
Topics: Acute Disease; Antibodies, Antineutrophil Cytoplasmic; Capillaries; Chest Pain; Child; Female; Hemor | 2019 |
A rare case of laparoscopy towards SLE with lupus mesenteric vasculitis induced ascites.
Topics: Abdomen, Acute; Administration, Intravenous; Administration, Oral; Antirheumatic Agents; Ascites; Fe | 2019 |
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colchicine; Comorbidity; Complement C1q; Female; France; | 2015 |
Chronic alveolar haemorrhage in a paediatric patient: a diagnostic and treatment challenge.
Topics: Adolescent; Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biopsy; C | 2015 |
Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus.
Topics: Adult; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Cutaneous; Lup | 2017 |
End-stage renal disease in patients with rheumatoid arthritis.
Topics: Adalimumab; Adolescent; Adult; Amyloidosis; Antirheumatic Agents; Arthritis, Rheumatoid; Biological | 2017 |
Systemic vasculitis developing after hydroxychloroquine interruption in a patient with Sjögren's syndrome.
Topics: Drug Administration Schedule; Female; Humans; Hydroxychloroquine; Lymphoma, B-Cell, Marginal Zone; M | 2010 |
Large leg ulcers due to autoimmune diseases.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; | 2011 |
A case of primary Sjögren's syndrome presenting primarily with central nervous system vasculitic involvement.
Topics: Adult; Angiography, Digital Subtraction; Azathioprine; Brain; Central Nervous System Diseases; Diagn | 2012 |
Intestinal vasculitis and renal infarction in a lupus patient with antiphospholipid syndrome.
Topics: Adolescent; Antiphospholipid Syndrome; Comorbidity; Drug Therapy, Combination; Female; Humans; Hydro | 2012 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermato | 2003 |
PENILE NODULES AS A MAJOR MANIFESTATION OF SUBACUTE ANGIITIS.
Topics: Humans; Hydroxychloroquine; Infectious Mononucleosis; Male; Neuritis; Pathology; Penis; Prednisone; | 1964 |
Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Electroretinography; Female; Humans; Hydroxychlo | 2005 |
Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Chilblains; Child; Cohort St | 2007 |
The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine.
Topics: Adult; Biopsy; Complement Activating Enzymes; Complement C1q; Hemolytic Plaque Technique; Humans; Hy | 1984 |
Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cohort Studies; Drug Therapy, Combination; Female; Foll | 1995 |
Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Hydroxych | 1993 |
Nonvasculitic neuritis.
Topics: Aged; Female; Humans; Hydroxychloroquine; Neuritis; Prednisone; Vasculitis | 1994 |